Lexeo Therapeutics, Inc. (LXEO)

SEC filing

Lexeo Therapeutics, Inc.

LXEO · CIK 1907108

4 · Sep 28, 2026 · Chief Financial Officer Tamayo Louis Edward was granted 54.75K Stock Option (right to buy)

Chief Financial Officer Tamayo Louis Edward was granted 54.75K Stock Option (right to buy)

xslF345X06/form4-09282026_050908.xml

xslF345X06/form4-09282026_050908.xmlSEC.gov

Graphics and non-inline formats (not embedded below).